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ABSTRACT 
Objective: To develop a simple, rapid, economic, accurate and precise reverse phase-high performance liquid chromatographic (RP-HPLC) method 
for the determination of hydrochlorothiazide and candesartan in the pharmaceutical dosage form and to validate as per international conference on 
harmonization (ICH) guidelines. 
Methods: The chromatographic separation was performed on Silanol BDS C18 column (250 x 4.6 mm, 5 μm), a mobile phase consisting of water (pH
Results: The developed method resulted in elution of hydrochlorothiazide at 2.28 min and candesartan at 4.28 min. The calibration curves were 
linear (r
 
adjusted to 2.8 with orthophosphoric acid): acetonitrile (30:70 % v/v), with a flow rate 1 ml/min and the detection wavelength of 210 nm using 
photodiode array (PDA) detector. 
2
Conclusion: A simple, economic, accurate, precise, linear and rapid RP-HPLC method was developed for simultaneous quantitative estimation of 
hydrochlorothiazide and candesartan in bulk and pharmaceutical formulation and the method was validated as per ICH guidelines. Hence, the 
method holds good for the routine analysis of hydrochlorothiazide and candesartan in various pharmaceutical industries as well as in academics. 
=0.999) in the concentration range of 6.25-18.75 μg/ml and 8-24 μg/ml for hydrochlorothiazide and candesartan respectively. The 
percentage recoveries were found to be 99.78-100.39 for hydrochlorothiazide and 99.87-100.64 for candesartan. The limit of detection (LOD) was 
found to be 0.410 μg/ml and 0.699 μg/ml for hydrochlorothiazide and candesartan respectively. The limit of quantitation (LOQ) was found to be 
1.367 μg/ml and 2.330 μg/ml for hydrochlorothiazide and candesartan respectively. 
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Hydrochlorothiazide [fig. 1] is chemically 6-chloro-1,1-dioxo-3,4-
dihydro-2H-1,2,4-benzothiadiazine-7-sulfonamide, belongs to the 
thiazide class of diuretics. The drug reduces extra fluid in the body 
caused by conditions such as heart failure and kidney disease. 
  
 
Fig. 1: Chemical structure of hydrochlorothiazide 
 
Candesartan [fig. 2] is chemically 1-((2'-(1H-tetrazol-5-yl)-[1,1'-
biphenyl]-4-yl)methyl)-2-ethoxy-1H-benzo[d]imidazole-7-carboxylic 
acid, belongs to the class of angiotensin II receptor blockers. It is 
used for treating high blood pressure (hypertension). 
 
 
Fig. 2: Chemical structure of candesartan 
A detailed literature survey revealed that there were analytical methods 
for the estimation of specified drugs with other combinations by 
ultraviolet spectroscopy (UV) [1-7], high-performance thin layer 
chromatography (HPTLC) [8], liquid chromatography/mass 
spectrometry/mass spectrometry (LCMS/MS) [9] and HPLC [10-12]. 
There were few RP-HPLC methods for the estimation of 
hydrochlorothiazide and candesartan[13-17] but the developed 
methods involve use of buffers as mobile phases which decrease the life 
of the column and has longer retention times, leading to more analysis 
time. Hence, an RP-HPLC method has been developed using simple 
mobile phase with less runtime.  
In the present work an easy, rapid, accurate and specific method was 
developed by using low-cost solvent water and acetonitrile for the 
simultaneous estimation of hydrochlorothiazide and candesartan in bulk 
and pharmaceutical dosage form. The developed method was validated 
as per validation of analytical procedures i.e. ICH guidelines: Q2 [R1] 
Validation of Analytical Procedures: Text and Methodology. 
MATERIALS AND METHODS 
Chemicals and reagents 
Pharmaceutical grade hydrochlorothiazide and candesartan were 
provided as a gift sample by Spectrum Pharma Labs, Hyderabad and 
the marketed formulation (Candesar-H, candesartan-16 mg, 
hydrochlorothiazide-12.5 mg) was purchased from local market, 
acetonitrile, orthophosphoric acid and HPLC grade water purchased 
from Merck. 
Instrument 
Chromatography was performed on Waters HPLC 2695 equipped 
with quaternary pumps with PDA detector. The chromatographic 
separation was performed using Silanol C18 column (4.5 x 250 
mmx5 μm). The data acquisition and integration were performed 
using Empower 2 software. 
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The developed method used a reverse phase C18 column, Silanol C18 
column (4.5 x 250 mm x 5 μm), a mobile phase consisting of water 
(pH
LOD and LOQ 
 adjusted to 2.8 with orthophosphoric acid): acetonitrile (30:70 
%v/v), flow rate of 1.0 ml/min and a detection wavelength of 210 
nm using PDA detector.  
Preparation of standard solutions 
Standard stock solutions of hydrochlorothiazide and candesartan 
were prepared by dissolving 12.5 mg of hydrochlorothiazide and 16 
mg of candesartan insufficient amount of mobile phase and 
sonicated for 5 min. After that, the solution was filtered and diluted 
to 10 ml with mobile phase. Further dilutions in five replicates were 
made to get the final concentration of 12.5 μg/ml and 16 μg/ml for 
hydrochlorothiazide and candesartan respectively. This has been 
treated as 100 % target concentration [18]. 
Preparation of sample solutions 
20 tablets were weighed, crushed and quantity of powder equivalent 
to 12.5 mg of hydrochlorothiazide and 16 mg of candesartan were 
weighed and transferred into a 10 ml volumetric flask, sufficient 
amount of mobile phase was added and sonicated for 5 min. After 
that, the solution was filtered and the volume was made up to 10 ml 
with mobile phase. Further dilutions in five replicates were made to 
get the final concentration of 12.5 μg/ml and 16 μg/ml for 
hydrochlorothiazide and candesartan respectively. 
Validation of the developed method 
The proposed analytical method was validated for system suitability, 
linearity and range, precision, LOD, LOQ and accuracy in accordance 
with ICH guidelines for analytical procedures Q2 [R1] [19]. 
System suitability 
System suitability parameters were studied to verify the system 
performance. Six replicate samples containing hydrochlorothiazide 
(12.5 μg/ml) and candesartan (16 μg/ml) were analyzed using the 
developed method. Factors such as theoretical plate count, tailing 
factor, percent relative standard deviation of peak area and 
retention time were taken into consideration for testing system 
suitability. 
Linearity and range 
The linearity was evaluated at six concentration levels in the range 
between 6.25-18.75 μg/ml and 8-24 μg/ml for hydrochlorothiazide 
and candesartan respectively. A calibration curve was obtained by 
plotting concentration against corresponding peak area and 
linearity was determined using least square regression analysis. The 
analytical range was established by the highest and lowest 
concentrations of analyte and the acceptable linearity was obtained 
with the specified analytical range. 
Precision 
The precision of the developed analytical method was carried out for 
same concentration level. Six determinations were performed and were 
expressed in terms of percent relative standard deviation [% RSD]. 
Limit of detection and quantitation of the developed method were 
calculated from the standard deviation of the y-intercept and slope 
of the calibration curve of hydrochlorothiazide and candesartan 
using the following formula:  
Limit of detection = 3.3 α/s 
Limit of quantitation = 10 α/s 
Where α is the standard deviation of the y-intercept and ‘s’ is the 
slope of the calibration curve. 
Accuracy 
Accuracy of the method has been studied by recovery experiment by 
applying the standard addition method. A known quantity of drug 
substance corresponding to 50%, 100%, and 150% of the label claim 
of drug were added, to determine if there are positive or negative 
interferences from excipients present in the formulation. Each set of 
addition were repeated three times. The accuracy was expressed as 
the percentage of analytes recovered by the assay.  
Application of validated method for assay of hydrochlorothiazide 
and candesartan in pharmaceutical dosage form 
Tablet powder equivalent to 12.5 mg of hydrochlorothiazide and 16 
mg of candesartan were weighed and transferred into a 10 ml 
volumetric flask, 7 ml of diluent was added and sonicated for 5 min. 
After that, the solution was filtered and the volume was made up to 
the mark with diluent. From this solution, further dilution was made 
to get the final concentration of 12.5 μg/ml of hydrochlorothiazide 
and 16 μg/ml of candesartan. The prepared solutions were injected 
into the HPLC system, chromatograms were recorded and from the 
peak areas of hydrochlorothiazide and candesartan, the amount of 
drug present in the sample was computed. 
RESULTS AND DISCUSSION 
Method development 
Different chromatographic conditions were tried for better separation 
and resolution. Silanol BDS C18 column (250×4.6 mm, 5 μm) was found 
satisfactory. Detection of analytes was carried out using PDA detector 
and 210 nm was considered satisfactory for detecting both the drugs 
with adequate sensitivity. A number of trails were performed with 
different solvents in the different ratios over a wide range of pH
But, either peak shape was broad or resolution was not good. 
Repeated trials to obtain good, sharp peaks with better retention times 
and efficient resolution between hydrochlorothiazide and candesartan 
were performed on Silanol BDS C
, with 
different flow rates and column temperatures.  
18 column. The runtime was good in 
isocratic trial with a flow rate of 1 ml/min using mobile phase 
containing water (pH
 
 adjusted to 2.8 with orthophosphoric 
acid):acetonitrile (30:70 % v/v) and the detection wavelength of 210 
nm using PDA detector gave satisfactory results in terms of retention 
time, resolution, symmetry and sensitivity. A typical RP-HPLC 
chromatogram for simultaneous determination of hydrochlorothiazide 
and candesartan from standard preparation and sample preparation 
was shown in fig. 3 and 4. 
 
Fig. 3: Standard chromatogram of hydrochlorothiazide and candesartan 
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Fig. 4: Sample chromatogram of hydrochlorothiazide and candesartan 
 
On comparison with literature, it is found that the mobile phase used 
by Rahul et al. [13] was phosphate buffer and acetonitrile. Quatab et 
al. [14] and Anand Rao et al. [15] used phosphate buffer and 
methanol. Whereas Mathrusri et al. [16] and Balamuralikrishna et al. 
[17] used 0.01 M tetrabutylammonium hydrogen sulphate: methanol 
and 0.02% triethylamine: acetonitrile respectively. All the methods 
used buffers in their mobile phases takes more preparation time and 
also the usage of buffers reduces the life of column. The retention 
time of drugs in the method developed by Rahul et al. [13] was 4.3 
min and 16.1 min, Anand Rao et al. [15] was 2.1 min and 7.2 min and 
Mathrusri et al. [16] was 2.7 min 8.1 min thereby increasing the 
analysis time. In the present study, a simple mobile phase consisting 
of water (pH
Method validation 
 adjusted with OPA) and acetonitrile was used which 
elute the hydrochlorothiazide and candesartan with lower retention 
time. 
System suitability 
Standard solutions were prepared as per the test method and 
injected into the chromatographic system. The system suitability 
parameters like theoretical plates, resolution and tailing factor were 
evaluated. The system suitability parameters were summarized in 
table 1. All the parameters were found to be within the limits. 
 
Table 1: Results of system suitability study 
Parameters Acceptance limits  Hydrochlorothiazide Candesartan 
Retention time* (min)  - 2.30±0.16 4.40±0.18 
Resolution* NLT 2  - 14.2±0.03 
Theoretical plates*  NLT 2000  6493±2 10170±4 
Tailing factor * NMT 2  1.23±0.02 1.05±0.03 
*=results of six determinations 
 
Linearity and range 
The linearity of the test solutions for the assay method was prepared 
from hydrochlorothiazide and candesartan standard stock solution at 
five concentration levels from 50% to 150% of assay concentration. The 
peak area versus concentration data was treated by least-square linear 
regression analysis. The results showed an excellent correlation between 
peak areas and concentration within the concentration range of 6.25-
18.75 μg/ml and 8-24 μg/ml for hydrochlorothiazide and candesartan 
respectively. The results of linearity of hydrochlorothiazide and 
candesartan were summarized in table 2. The correlation coefficients 
were found to be 0.999 for both hydrochlorothiazide and candesartan, 
which meet the method validation acceptance criteria and hence the 
method was said to be linear for both the drugs. The results showed that 
a linear relationship between peak area and concentration of the drug in 
the calibration curve. 
  
Table 2: Linearity data for hydrochlorothiazide and candesartan 
% level  Hydrochlorothiazide 




concentration (μg/ml)  
Candesartan peak 
area  
50 6.25 292718 8 626266 
75 9.37 408707 12 909947 
100 12.50 544937 16 1213266 
125 15.62 681175 20 1516578 




Slope 43031 77306 
 
Accuracy  
The accuracy of the method was determined by recovery studies 
by the determination of % mean recovery of both the drugs at 
three different levels (50 %, 100 % and 150%). At each level, 
three determinations were performed. The percentage recovery 
and mean percentage recovery were calculated for the drugs and 
presented in table 3. The observed data were within the 
specified range. Hence good recovery values indicate that the 
developed method is accurate for the determination of specified 
drugs. 
Precision 
Method precision  
The precision of the method was verified by precision method 
studies. The sample solution was prepared at working concentration 
and analysis was carried out at replicates. The sample solutions of 
hydrochlorothiazide and candesartan were prepared as per the test 
method and injected six times into the column. The results of 
precision were tabulated in table 4. The mean of peak area was 
calculated, % RSD was calculated and reported. Method precision % 
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RSD values lower than 2% clearly assured that the developed method was found to be fairly precise and reproducible. 
  
Table 3: Results of accuracy 
Level (%) Hydrochlorothiazide Candesartan 
% recovery % mean recovery  % recovery % mean recovery* 
50 99.59 99.78 99.89 99.87 
50 99.75  99.78  
50 100.01  99.96  
100 99.50 99.57 100.87 101.08 
100 99.99  101.63  
100 99.23  100.76  
150 100.10 100.39 101.45 100.64 
150 101.00  100.66  
150 100.08  99.83  
*Average of triplicate determinations; Acceptence criteria: % recovery must be 98%-102% 
 
Table 4: Method precision data for hydrochlorothiazide and candesartan 
No. of injections Hydrochlorothiazide Candesartan 
Rt peak area Rt peak area 
Injection 1  2.286 544936 4.462 1213265 
Injection 2  2.287 544933 4.485 1213266 
Injection 3  2.291 544940 4.491 1213267 
Injection 4  2.301 544936 4.488 1213259 
Injection 5  2.302 544939 4.487 1213258 
Injection 6 2.299 544938 4.480 1213262 
Mean*±SD 544937±2.52  0.4 1213263±3.76 0.3 
% RSD  #  
*The value is represented as a mean±SD of 6 observations (n=6), SD: Standard Deviation, #RSD: Relative Standard Deviation, Acceptance criteria:<2 
 
Limit of detection and limit of quantitation 
LOD and LOQ were estimated from the standard deviation of the y-
intercept and slope of the calibration curve of hydrochlorothiazide 
and candesartan.  
The LOD and LOQ were found to be 0.410 μg/ml and 1.367 μg/ml for 
hydrochlorothiazide and 0.699 μg/ml and 2.330 μg/ml for 
candesartan. The results of LOD and LOQ specified the sensitivity of 
the developed method. 
Robustness 
Robustness of the developed method was determined by 
deliberately altering the experimental conditions and the system 
suitability parameters were evaluated. The solutions prepared as 
per the test method and injected at different variable conditions like 
flow rate (0.8, 1.2 ml/min) and wavelength (208 nm, 212 nm), 
system suitability parameters were compared with that of method 
precision.  
The results were tabulated in table 5. Even though, small changes 
were made in the conditions there was no significant effect on 
tailing, plate count and retention time of specified drugs. Hence, the 
developed method was found to be robust. 
Application of validated method for assay of hydrochlorothiazide 
and candesartan in pharmaceutical dosage form 
The developed method was successfully implemented in the assay of 
hydrochlorothiazide and candesartan in pharmaceutical dosage 
form. Assay of hydrochlorothiazide and candesartan was found to be 
99.16% and 99.60% respectively. The results of the assay were 
summarized in table 6. 
 
Table 5: Results of robustness 
Parameter Hydrochlorothiazide Candesartan 
Plate count Tailing* # Plate count Tailing*  # 
Less flow rate (0.8 ml/min)  5416 1.21 9606 1.11 
More flow rate (1.2 ml/min)  6692 1.19 8807 1.04 
Less wavelength (208 nm) 3284 1.09 9875 1.12 
More wavelength (212 nm)  6217 1.17 9294 1.09 
Acceptance criteria (Limits): #Peak Asymmetry: >2000, *Tailing: <2 
 
Table 6: Assay of hydrochlorothiazide and candesartan in pharmaceutical dosage form 
Name  Standard average area* Sample average area* % Assay 
Hydrochlorothiazide 544837 534811 99.16 
Candesartan 1213262 1208408 99.60 
*Mean of six determinations 
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In the present study, a simple and efficient RP-HPLC method was 
developed for the simultaneous analysis of hydrochlorothiazide and 
candesartan in bulk and in pharmaceutical dosage form. The method 
was validated as per ICH guidelines and found to be applicable for 
routine quality control analysis. The results of analysis of 
pharmaceutical formulation by the proposed method were highly 
reproducible and reliable. Hence, it can be concluded that the 
proposed RP-HPLC method was simple, cost-effective, specific, 
accurate, precise, robust and rapid.  
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